Woman smiling in a field Woman smiling in a field

For eligible adults with newly diagnosed FLT3-ITD+ AML, Only VANFLYTA®
specifically targets
the FLT3-ITD mutation

VANFLYTA is a prescription medicine used in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia (AML) with a
FLT3-ITD mutation.

VANFLYTA is not for use alone as maintenance therapy after a hematopoietic stem cell transplant.

Mutations in AML

What is AML?

Find out more about your or your loved one’s disease and the FLT3-ITD mutation

Doctor reviewing data with two adults


Learn how VANFLYTA is taken

Daiichi Sankyo Support portrayal


Discover how Daiichi Sankyo may be able to assist you throughout VANFLYTA treatment